RUDY RAMIREZ: Open Payments
NPI 1457660359 · CORONA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$306 in 14 payments from 8 companies in 2025. Trend: 2023 $1,489 · 2024 $825 · 2025 $306
Food & beverage: $306
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $112 |
| Lilly USA, LLC | 2 | $54 |
| Abbott Laboratories | 2 | $29 |
| ABBVIE INC. | 1 | $27 |
| Spinal Simplicity, LLC | 1 | $25 |
| Collegium Pharmaceutical, Inc. | 1 | $23 |
| PFIZER INC. | 1 | $22 |
| SCILEX PHARMACEUTICALS INC. | 1 | $13 |
Products named: RELISTOR, EMGALITY, PROCLAIM, QULIPTA, HA MINUTEMAN G3-R, XTAMPZA, NURTEC ODT, ZTLido.
Industry payments across CA — which companies pay providers there.
